Clinical Trial

Safety and Effectiveness of Valbenazine as Adjunct Therapy to Botulinum Toxin Injections in Cervical Dystonia

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The most common form of idiopathic dystonia is adult-onset cervical dystonia (CD), a focal form of dystonia affecting the muscles of the neck. CD is often associated with pain and limited range of motion, and frequently leads to reduced quality of life and disability. Effective long-term treatment options are extremely limited. Recurring botulinum neurotoxin (BoNT) injections can ease the symptoms of CD, but they frequently provide only partial relief and can be associated with intolerable side effects. Deep brain stimulation can be used to treat more severe cases of CD, but this neurosurgical procedure is invasive, on average only about 50% effective and may lead to serious adverse effects. Novel treatment approaches for CD are desperately needed to alleviate symptoms and improve the quality of life for the many who suffer from this chronic and disabling neurological disorder.
Protocol Amendment History 4 changes
notable Primary completion pushed: 2026-05 -> 2027-06 2026-06-05
minor Completion pushed: 2026-05 -> 2027-06 2026-06-05
notable Primary completion pushed: 2026-04 -> 2026-05 2026-05-12
minor Completion pushed: 2026-04 -> 2026-05 2026-05-12
Trial Details
NCT Number NCT06771323
Lead Sponsor Virginia Commonwealth University
Conditions Cervical Dystonia
Enrollment 20 participants
Start Date 2024-12-17
Primary Completion 2027-06 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-06-04